Defining post-transcriptional mechanisms that control CD8 T cell longevity, proliferation and differentiation

定义控制 CD8 T 细胞寿命、增殖和分化的转录后机制

基本信息

  • 批准号:
    10308478
  • 负责人:
  • 金额:
    $ 54.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-12-06 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY CD8 T cells play a critical role in the elimination of infected and cancerous host cells. The success of these immune responses depends on the proper maintenance (survival and proliferation) and precise differentiation of CD8 T cells. Upon antigen stimulation, activated antigen-specific CD8 T cells undergo clonal expansion and differentiate into effector lymphocytes with cytolytic function. Although the majority of effector cells die after antigen clearance, a few antigen-specific cells survive and form long-lived protective memory CD8 T cells. However, during chronic infection and cancer, the immune response is often compromised: CD8 T cells exhibit defects in survival and proliferation, fail to form memory cells and instead are diverted to differentiate into exhausted cells which are characterized by the loss of effector function. Thus, it is of utmost importance to understand the underlying mechanisms that regulate the maintenance and differentiation of CD8 T cells. We have already demonstrated that let-7-mediated posttranscriptional mechanism controls the differentiation and function of effector T cells. Furthermore, our preliminary results suggest that modulation of let-7 levels have a profound impact on the maintenance of T cells, memory formation and diversion into exhaustion. To investigate the molecular mechanisms of let-7 regulation in CD8 T cells we propose the following aims: Aim-1 will determine the molecular basis of let-7-mediated effects on CD8 T cell maintenance: bcl-2-dependent survival and cdc34-driven proliferation. Aim-2 will dissect let-7-mediated mechanisms that guide CD8 T cell differentiation: Eomes-dependent and Eomes-independent molecular programs. To address these aims we will analyze the maintenance and differentiation of CD8 T cells with different levels of let-7 microRNAs into effector, memory and exhausted T lymphocytes using infection and tumor models. We expect to identify novel posttranscriptional mechanisms that regulate the outcome of CD8 T cell-mediated immune responses. It is anticipated that these experiments will define let-7 as a new therapeutic target.
项目概要 CD8 T 细胞在消除受感染和癌性宿主细胞中发挥着关键作用。这些的成功 免疫反应取决于适当的维持(生存和增殖)和精确分化 CD8 T 细胞。抗原刺激后,活化的抗原特异性 CD8 T 细胞进行克隆扩增并 分化为具有溶细胞功能的效应淋巴细胞。尽管大多数效应细胞在 抗原清除后,一些抗原特异性细胞存活并形成长寿命的保护性记忆 CD8 T 细胞。 然而,在慢性感染和癌症期间,免疫反应常常受到损害:CD8 T 细胞表现出 生存和增殖缺陷,无法形成记忆细胞,而是转向分化为 疲惫的细胞,其特征是效应器功能丧失。因此,至关重要的是 了解调节 CD8 T 细胞维持和分化的潜在机制。我们 已经证明let-7介导的转录后机制控制分化和 效应T细胞的功能。此外,我们的初步结果表明,let-7 水平的调节具有 对 T 细胞的维持、记忆的形成和疲劳的转移产生深远的影响。调查 针对 CD8 T 细胞中 let-7 调节的分子机制,我们提出以下目标: Aim-1 将确定 let-7 介导的 CD8 T 细胞维持作用的分子基础:bcl-2 依赖性 生存和 cdc34 驱动的增殖。 Aim-2 将剖析 let-7 介导的引导 CD8 T 细胞的机制 分化:依赖于 Eomes 和不依赖于 Eomes 的分子程序。为了实现这些目标,我们将 分析具有不同水平let-7 microRNA的CD8 T细胞维持和分化为效应细胞的情况, 使用感染和肿瘤模型进行记忆和耗尽的 T 淋巴细胞。我们期望识别出新颖的 调节 CD8 T 细胞介导的免疫反应结果的转录后机制。这是 预计这些实验将把let-7定义为新的治疗靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Leonid Pobezinskiy其他文献

Leonid Pobezinskiy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Leonid Pobezinskiy', 18)}}的其他基金

Defining post-transcriptional mechanisms that control CD8 T cell longevity, proliferation and differentiation
定义控制 CD8 T 细胞寿命、增殖和分化的转录后机制
  • 批准号:
    10066307
  • 财政年份:
    2019
  • 资助金额:
    $ 54.07万
  • 项目类别:
Defining post-transcriptional mechanisms that control CD8 T cell longevity, proliferation and differentiation
定义控制 CD8 T 细胞寿命、增殖和分化的转录后机制
  • 批准号:
    10526397
  • 财政年份:
    2019
  • 资助金额:
    $ 54.07万
  • 项目类别:
Defining post-transcriptional mechanisms that control CD8 T cell longevity, proliferation and differentiation
定义控制 CD8 T 细胞寿命、增殖和分化的转录后机制
  • 批准号:
    9912626
  • 财政年份:
    2019
  • 资助金额:
    $ 54.07万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.07万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.07万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 54.07万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.07万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.07万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.07万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.07万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 54.07万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 54.07万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 54.07万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了